Brief: Bone Biologics Corp Gets Notice Of Delisting Or Failure To Satisfy A Continue Listing Rule Or Standard From Nasdaq
21/11/2022 23:23
Nov 21 (Reuters) - Bone Biologics Corp BBLG.O :
* BONE BIOLOGICS CORP- ON NOV 17, GOT NOTICE OF DELISTING OR
FAILURE TO SATISFY A CONTINUE LISTING RULE OR STANDARD FROM
NASDAQ
Source: (shorturl.at/bdlw1)
Further company coverage: BBLG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview